What Is Quince Therapeutics, Inc. (QNCX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Quince Therapeutics, Inc.'s intrinsic value is estimated at $6.57. Trading at its current price of $17.25, the valuation engine raises significant caution: 12 of 12 models flag downside risk, projecting an average implied return of -61.9%. Model dispersion is worth noting: EPV targets $13.43 (-22.2%), versus Sentiment SOTP at $0.19 (-98.9%). This +76.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About QNCX?
12 of 13 models are currently active for QNCX. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates QNCX's intrinsic value at $2.33, implying -86.5% downside from the current price. See which stocks rank higher →
How Does QNCX Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, QNCX ranks #92 by Quality of Company score. CirclFi's QOC score of 4.6/10 evaluates 32 fundamental signals. A score of 4.6 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Quince Therapeutics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is QNCX a Value Trap?
CirclFi's Value Trap algorithm assigns QNCX a score of 37/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Quince Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Quince Therapeutics, Inc. scores 4.6 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +76.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every QNCX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across QNCX's 12 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad